Medicamen Biotech

quarterly
yearly
ParticularsDec '22Mar '23Jun '23Sep '23Dec '23
Revenue36.2139.0242.3244.0947.33
Expenses31.9934.6637.6441.6344.06
EBITDA6.506.837.335.195.72
EBIT4.905.225.643.373.92
Profit Before Tax4.224.364.692.473.27
Net Profit3.773.773.951.482.03
Financial Ratios
Operating Profit Margin18.30%17.69%17.48%11.92%12.30%
Net Profit Margin10.57%10.06%9.97%3.47%4.37%
Earning Per Share (Diluted)2.983.033.121.171.60
Dividends Per Share0.000.000.000.000.00
ⓒ 2016-2024 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 4.7.6
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK MAHINDRA |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  BANDHAN |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  IDBI |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ |  BAJAJ